These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25962737)

  • 1. Hypertrophic adenoids in patients with nasopharyngeal carcinoma: appearance at magnetic resonance imaging before and after treatment.
    Wu YP; Cai PQ; Tian L; Xu JH; Mitteer RA; Fan Y; Zhang Z
    Chin J Cancer; 2015 Mar; 34(3):130-6. PubMed ID: 25962737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.
    Buehrlen M; Zwaan CM; Granzen B; Lassay L; Deutz P; Vorwerk P; Staatz G; Gademann G; Christiansen H; Oldenburger F; Tamm M; Mertens R
    Cancer; 2012 Oct; 118(19):4892-900. PubMed ID: 22359313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal mucosa and adenoids: appearance at MR imaging.
    Bhatia KS; King AD; Vlantis AC; Ahuja AT; Tse GM
    Radiology; 2012 May; 263(2):437-43. PubMed ID: 22403169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Qi S; Zhongyi Y; Yingjian Z; Chaosu H
    Sci Rep; 2017 Jan; 7():40552. PubMed ID: 28091565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel technique of endonasopharyngeal ultrasound-guided transnasopharyngeal needle aspiration in the diagnosis of submucosal recurrence of nasopharyngeal carcinoma after chemoradiotherapy.
    Zhang ZM; Zhao R; Bao Y; Zhou LX; Chen X; Liu WS; Li SP; Hu SZ; Wang RL
    Radiother Oncol; 2021 Dec; 165():14-19. PubMed ID: 34627938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal granulomatous mass after radiotherapy for nasopharyngeal carcinoma.
    Yang L; Li H; Wang H; Zhang H; Wang S; Fry AN; Han WW; Wang D
    Auris Nasus Larynx; 2016 Jun; 43(3):330-5. PubMed ID: 26791589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based diagnosis of residual or recurrent nasopharyngeal carcinoma may be a phantom tumor phenomenon.
    Lee CC; Lee JC; Huang WY; Juan CJ; Jen YM; Lin LF
    Medicine (Baltimore); 2021 Feb; 100(8):e24555. PubMed ID: 33663063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
    Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
    J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor regression patterns by follow-up duration in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy.
    Kong M; Hong SE
    J Radiat Res; 2017 Mar; 58(2):232-237. PubMed ID: 27738079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital's experience.
    Jiang F; Jin T; Feng XL; Jin QF; Chen XZ
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C179-84. PubMed ID: 26506872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of MRI for the diagnosis of recurrence of nasopharyngeal cancer.
    Fujii M; Kanzaki J
    Auris Nasus Larynx; 1994; 21(1):32-7. PubMed ID: 7980192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
    Setakornnukul J; Thephamongkhol K
    BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in extension patterns between adenoid cystic carcinoma of the nasopharynx and nasopharyngeal carcinoma on MRI.
    Dong J; Tian L; Li S; Mo Y; Liu L; Zhong R
    Int J Clin Exp Pathol; 2015; 8(12):15960-8. PubMed ID: 26884870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of positron emission tomography on primary tumour delineation and dosimetric outcome in intensity modulated radiotherapy of early T-stage nasopharyngeal carcinoma.
    Wu VW; Leung WS; Wong KL; Chan YK; Law WL; Leung WK; Yu YL
    Radiat Oncol; 2016 Aug; 11(1):109. PubMed ID: 27558690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis.
    Hu CY; Huang SF; Ho WL; Chuang WY; Chan KC
    Auris Nasus Larynx; 2017 Dec; 44(6):754-757. PubMed ID: 27884592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.
    Ke LR; Xia WX; Qiu WZ; Huang XJ; Yang J; Yu YH; Liang H; Liu GY; Ye YF; Xiang YQ; Guo X; Lv X
    BMC Cancer; 2017 Feb; 17(1):134. PubMed ID: 28202000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
    Johnson FM; Garden A; Palmer JL; Kies M; Clayman G; Brumfield B; Khuri FR; Morrison W; Papadimitrakopoulou V; Diaz EM; Glisson BS
    Cancer; 2004 Mar; 100(5):991-8. PubMed ID: 14983495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.